Paper39634409
Revolutionizing medicine: Harnessing plant-derived vesicles for therapy and drug transport.
Lv L and 10 others. Heliyon, 2024. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. Revolutionizing medicine: Harnessing plant-derived vesicles for therapy and drug transport. Papers, record 39634409. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39634409
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Revolutionizing medicine: Harnessing plant-derived vesicles for therapy and drug transport.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References159
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28104520 | Extracellular vesicle docking at the cellular port: Extracellular vesicle binding and uptake. | Semin Cell Dev Biol | 2017 | https://conductscience.org/library/papers/28104520 | PubMed |
| 2 | 27979573 | Extracellular Vesicles: Unique Intercellular Delivery Vehicles. | Trends Cell Biol | 2017 | https://conductscience.org/library/papers/27979573 | PubMed |
| 3 | 33017912 | A new approach for COVID-19 treatment by micro-RNA. | Med Hypotheses | 2020 | https://conductscience.org/library/papers/33017912 | PubMed |
| 4 | 33160961 | Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles as novel cell-free therapy for treatment of autoimmune disorders. | Exp Mol Pathol | 2021 | https://conductscience.org/library/papers/33160961 | PubMed |
| 5 | 24915381 | Effect of processing on phenolic antioxidants of fruits, vegetables, and grains--a review. | Crit Rev Food Sci Nutr | 2015 | https://conductscience.org/library/papers/24915381 | PubMed |
| 6 | 32648899 | Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. | JAMA | 2020 | https://conductscience.org/library/papers/32648899 | PubMed |
| 7 | 35448322 | Plant-RNA in Extracellular Vesicles: The Secret of Cross-Kingdom Communication. | Membranes (Basel) | 2022 | https://conductscience.org/library/papers/35448322 | PubMed |
| 8 | 30706777 | Exosome-like Nanoparticles: A New Type of Nanocarrier. | Curr Med Chem | 2020 | https://conductscience.org/library/papers/30706777 | PubMed |
| 9 | 36978093 | Plant-derived extracellular vesicles (PDEVs) in nanomedicine for human disease and therapeutic modalities. | J Nanobiotechnology | 2023 | https://conductscience.org/library/papers/36978093 | PubMed |
| 10 | 28274798 | Broccoli-Derived Nanoparticle Inhibits Mouse Colitis by Activating Dendritic Cell AMP-Activated Protein Kinase. | Mol Ther | 2017 | https://conductscience.org/library/papers/28274798 | PubMed |
| 11 | 32690102 | An efficient method to isolate lemon derived extracellular vesicles for gastric cancer therapy. | J Nanobiotechnology | 2020 | https://conductscience.org/library/papers/32690102 | PubMed |
| 12 | 27943215 | Bioinformatics Tools for Extracellular Vesicles Research. | Methods Mol Biol | 2017 | https://conductscience.org/library/papers/27943215 | PubMed |
| 13 | 37984504 | Therapeutic potential of plant-derived extracellular vesicles as nanocarriers for exogenous miRNAs. | Pharmacol Res | 2023 | https://conductscience.org/library/papers/37984504 | PubMed |
| 14 | 31775862 | Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth. | J Immunother Cancer | 2019 | https://conductscience.org/library/papers/31775862 | PubMed |
| 15 | 36139376 | Immunological Effects of Aster yomena Callus-Derived Extracellular Vesicles as Potential Therapeutic Agents against Allergic Asthma. | Cells | 2022 | https://conductscience.org/library/papers/36139376 | PubMed |
| 16 | 25883092 | Grapefruit-Derived Nanovectors Use an Activated Leukocyte Trafficking Pathway to Deliver Therapeutic Agents to Inflammatory Tumor Sites. | Cancer Res | 2015 | https://conductscience.org/library/papers/25883092 | PubMed |
| 17 | 39062803 | A Systematic Review on Plant-Derived Extracellular Vesicles as Drug Delivery Systems. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39062803 | PubMed |
| 18 | 36276815 | Anti-fibrotic effect of extracellular vesicles derived from tea leaves in hepatic stellate cells and liver fibrosis mice. | Front Nutr | 2022 | https://conductscience.org/library/papers/36276815 | PubMed |
| 19 | 33036916 | Rhizospheric Plant-Microbe Interactions: miRNAs as a Key Mediator. | Trends Plant Sci | 2021 | https://conductscience.org/library/papers/33036916 | PubMed |
| 20 | 28665164 | Oral administration of ginger-derived nanolipids loaded with siRNA as a novel approach for efficient siRNA drug delivery to treat ulcerative colitis. | Nanomedicine (Lond) | 2017 | https://conductscience.org/library/papers/28665164 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42793979 | Fruit- and Vegetable-Derived Exosome-like Nanovesicles: A Review. | Foods | 2026 | https://conductscience.org/library/papers/42793979 | PubMed |
| 42499705 | Chinese herbal medicine-derived exosome-like nanovesicles for orthopaedic diseases: evidence, methods, and translation. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42499705 | PubMed |
| 42278248 | Regenerative Approaches to Enhance the Skin Microenvironment and Boost Aesthetic Efficacy: A Narrative Review. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42278248 | PubMed |
| 42232745 | Curcuma-derived nanovesicle-loaded ROS-responsive hydrogels reprogram iron metabolism to enhance cartilage regeneration after microfracture. | Bioact Mater | 2026 | https://conductscience.org/library/papers/42232745 | PubMed |
| 42194053 | Plant-Derived Nanovesicles: A Comprehensive Review from Isolation to Clinical Translation-Unlocking Natural Nanocarriers for Biomedical Applications. | Biomolecules | 2026 | https://conductscience.org/library/papers/42194053 | PubMed |
| 42183055 | Mammalian, plant, and gut microbiota-derived extracellular vesicles as emerging therapeutics for bone diseases. | Front Bioeng Biotechnol | 2026 | https://conductscience.org/library/papers/42183055 | PubMed |
| 42123607 | Sulforaphane-Activated Functional Nucleic Acids for Cancer Therapy: Mechanisms, Delivery Strategies, and Nanomedicine Advances. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42123607 | PubMed |
| 42005709 | Research Progress and Preclinical Prospects of Plant-Derived Extracellular Vesicles in Targeted Delivery of Antitumor Drugs. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42005709 | PubMed |
| 41736037 | Extracellular vesicles derived from Citrus plants: innovative applications in therapeutics and drug delivery. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/41736037 | PubMed |
| 41400892 | Plant-derived extracellular vesicles quality control: key process progress and future research directions. | Discov Nano | 2025 | https://conductscience.org/library/papers/41400892 | PubMed |
| 40686092 | Dermatologically Tested Apple-Derived Extracellular Vesicles: Safety, Anti-Aging, and Soothing Benefits for Skin Health. | J Cosmet Dermatol | 2025 | https://conductscience.org/library/papers/40686092 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39634409
GET https://conductscience.org/api/papers/v1/39634409/references?page=2